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Abstract
BACKGROUND—The etiopathogenesis of microtia is still unknown in the majority of the cases,
particularly for individuals presenting with isolated microtia. Our aim was to evaluate potential
risk factors for this condition using a case-control approach.
METHODS—We analyzed data from 1,194 livebirths with isolated microtia enrolled in the
ECLAMC study (Estudio Colaborativo Latino Americano de Malformaciones Congénitas) from
1982 to 2011 and their respective controls. Odds ratios were estimated with conditional logistic
regression models along with 95% confidence intervals for the resulting odds ratio estimates
controlling for the effects of potential confounders (sex, maternal age, hospital and year of birth)
for an adjusted OR (aOR).
RESULTS—Multiparity was associated with a higher risk of microtia compared to primiparity
(aOR 1.5, 95%CI 1.2–1.8), with women who had eight or more prior pregnancies having the
highest risk (aOR 2.8, 95%CI 1.6–5.2). Women who presented with cold-like symptoms were at
higher risk for microtia (aOR 2.2, 95%CI 1.2–3.9) as well as those that used tobacco or alcohol
during pregnancy (aOR 1.7, 95%CI 1.1–2.5 and aOR 1.4, 95%CI 0.9–2.1, respectively). The
association with alcohol use appeared to be limited to those women who reported binge drinking
during pregnancy (aOR 1.4, 95% 0.7–2.9). Cases from hospitals at low altitude (< 2,500 m) tended
to have more severe types of microtia than those from hospitals at high altitude.
CONCLUSIONS—These results support the hypothesis that in addition to teratogens other non-
genetic risk factors contribute to the occurrence of isolated microtia.
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INTRODUCTION
Microtia is a congenital anomaly of the auricle ranging from mild structural abnormalities to
complete absence of the ear (Stevenson, 2006). Microtia may occur as an isolated condition
(‘isolated microtia’), or as part of a spectrum of anomalies or a syndrome. It can occur
unilaterally (79–93%) or bilaterally (Suutarla et al., 2007) and is more likely to affect the
right ear (~60%; (Suutarla et al., 2007). The pathogenesis of microtia is poorly understood.
Case series suggest that teratogens such as gestational exposure to retinoids, alcohol,
thalidomide, and the immunosuppressant mycophenolate mofetil, can be associated with
microtia (Anderka et al., 2009; Stevenson, 2006). Microtia occurs more often in males and
has been associated with multiple gestations (Forrester and Merz, 2005; Shaw et al., 2004);
advanced parental age (Castilla and Orioli, 1986; Forrester and Merz, 2005; Harris et al.,
1996); higher parity (Castilla and Orioli, 1986; Forrester and Merz, 2005; Harris et al., 1996;
Mastroiacovo et al., 1995); low maternal education (Husain et al., 2008; Shaw et al., 2004);
low birth weight (Castilla and Orioli, 1986; Forrester and Merz, 2005; Mastroiacovo et al.,
1995); maternal illness (Castilla and Orioli, 1986); and high altitude, as defined by higher
than 2,500m or 8,200 feet(Castilla et al., 1999). In addition, higher risk for individuals of
Asian heritage (Forrester and Merz, 2005; Harris et al., 1996; Shaw et al., 2004), Pacific
Islanders (Forrester and Merz, 2005), Native Americans (Aase and Tegtmeier, 1977; Jaffe,
1969; Nelson and Berry, 1984), and individuals of Hispanic descent (Canfield et al., 2009a;
Harris et al., 1996; Shaw et al., 2004; Yang et al., 2004) when compared to Caucasians and
African Americans has been reported.
Previous risk factor studies of microtia were limited by the following limitations: 1) most
are based on relatively small number of cases; 2) only a limited number of risk factors have
been addressed (for example, only two studies analyzed prenatal risk factors such as
maternal acute or chronic illnesses and use of medications, alcohol and tobacco;(Castilla and
Orioli, 1986; Mastroiacovo et al., 1995); 3) few distinguished between syndromic and
isolated cases (Canfield et al., 2009a; Castilla and Orioli, 1986; Mastroiacovo et al., 1995;
Shaw et al., 2004; Zhang et al., 2009), and 4) few involved control groups for comparison
(Castilla and Orioli, 1986; Mastroiacovo et al., 1995; Van Bennekom et al., 2013; Zhang et
al., 2009). The previous study in the South America population also used the ECLAMC
network data; however that dataset consisted of isolated and syndromic cases of microtia
from 1967 to 1977 during which the network had fewer hospitals participating. The current
analysis used more recent data (1982–2011) and includes other risk factors not investigated
in the prior study.
The objective of this study was to identify potential risk factors associated with microtia
using a case-control approach. We hypothesized that the occurrence of microtia is associated
with specific risk factors, including exposures during the mother’s pregnancy and race/
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ethnicity. Identification of potential modifiable risk factors for microtia will provide new
insights into its etiology and prevention strategies.
METHODS
Study population
ECLAMC (Estudio Colaborativo Latino Americano de Malformaciones Congénitas) is a
research group dedicated to the study of the epidemiology and etiology of birth defects using
a hospital-based case-control study in South America. ECLAMC’s methodology has been
described in detail elsewhere.(Castilla and Orioli, 2004) Briefly, trained physicians conduct
active ascertainment of newborns with birth defects (cases) through daily physical
examination of all births at participating hospitals; birth defects are described in detail
according to the ECLAMC manual of procedures. Each identified case is matched to a
control as follows: they are the subsequent infant born of the same sex, born sequentially
after the case in the same hospital; with no identified birth defect whose mothers agree to
participate (approximately 95 % of potential controls agree to participate). The mothers of
cases and controls are interviewed during the birth hospitalization, using a standardized
ECLAMC form; a questionnaire designed to collect the newborn physical examination,
prenatal history, demographic information, and family history of birth defects.
We included all live-births coded in ECLAMC database as having isolated microtia born
from 1982 through 2011. In order to minimize the potential heterogeneity of the case group
we did not include microtia cases with additional unrelated congenital anomalies; this
heterogeneity might obscure risk factors involved specifically in the development of isolated
microtia. Cases with microtia were considered isolated if they did not present any other
malformation or if they only presented selected minor congenital anomalies. (For list of
anomalies considered minor for the purpose of this study, please see appendix 1).
In ECLAMC, controls are not assigned to stillbirths, therefore stillborn cases were excluded
from this analysis, they constituted 1.1% (n=13) of all isolated microtia cases.
Covariates and potential risk factors
We included the following factors as part of cases’ phenotypic description: laterality,
severity (microtia: I–IV, according to Marx classification), birth weight, and sex. We
explored the following exposures as potential risk factors: acute and chronic maternal
illness; plurality, smoking; ingestion of alcohol, medications, or drugs; parity; parental ages,
occupation and education level; consanguinity; family history, and self-described race/
ethnicity. Information on some of these exposures were only collected after 2002, this is
indicated in the tables.
Statistical Analysis
We used standard methods for the analysis of case-control data. Although controls were
individually matched to cases, in order to perform subgroup analyses and maximize our
ability to detect associations between rare exposures and microtia, we fit logistic regression
models to estimate associations between proposed risk factors and microtia risk along with
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95% confidence intervals for the resulting odds ratio (OR) estimates. We individually
assessed the risk of microtia with exposures of interest, while controlling for potential
confounders. Control for confounding was carried out using a set of covariates determined a
priori base on a literature review; we adjusted models for the matching variables (sex,
hospital and year of birth) as well as maternal age to calculate an adjusted OR (aOR). We
only reported ORs for exposures that had at least five exposed cases. We performed
subgroup analysis including only those cases and controls without a family history of
microtia.
RESULTS
There were a total of 1,194 cases of isolated microtia; of those 56.6% were males. Microtia
was unilateral in 82.0% of cases, and in 65.6% of those the right side was affected. Cases
and controls did not differ substantially with respect to birth weight, gestational age,
plurality, maternal age, maternal education, paternal occupation, parental consanguinity and
race/ethnicity (Tables 1 and 2).
Multiparous women had a higher risk of microtia in their offspring compared to primiparous
women, this association was stronger among women who had eight or more prior
pregnancies (aOR 1.5, 95%CI 1.2–1.8 and aOR 2.8, 95%CI 1.6–5.2, respectively); these
findings were similar across groups defined by interpregnancy interval. Women who
smoked during pregnancy had a 70% higher risk of having a child with microtia relative to
non-smokers (95%CI 1.1–2.6); the risk was similar for those who smoked fewer than 10 or
10 or more cigarettes per day. While women who consumed alcohol during pregnancy also
presented a higher risk of having a child with microtia (aOR 1.4, 95%CI 0.9–2.1), this
association appeared to be limited to those women who reported binge drinking at least once
during pregnancy (aOR 1.4, 95% 0.7–2.9), however, these observations may have been due
to chance. Women that were employed outside the home had a 30% higher risk of having
offspring with microtia than women who reported being housewives (95% CI 1.1–1.5; Table
2).
Diagnosis of any acute or chronic disease at anytime during pregnancy was associated with
an elevated risk of microtia (aOR 1.4, 95%CI 1.2–1.6 and aOR 1.3, 95%CI 1.0–1.7,
respectively; Table 2). When we evaluated risk of microtia by specific conditions reported
during the first trimester; we found that report of cold-like symptoms was associated with
risk of microtia (aOR 2.2, 95%CI 1.2–3.9). We also found women who reported nausea,
asthma or respiratory infections had a 40–270% higher risk of having a child with microtia,
however these estimates were based on cells with fewer than 5 individuals and so were
statistically imprecise (Table 3).
The reported use of any medication during the first trimester of pregnancy was associated
with a higher risk for having a child with microtia (aOR 1.5, 95%CI 1.3–1.8; Table 3).
Specific medications that were associated with microtia were: analgesics, antiemetics,
antibiotics antihypertensives, antispasmodics, drugs for functional bowel disorders and
hormones. While all classes of analgesics were associated with a 2-fold or higher microtia
risk, acetaminophen was the most frequently reported and the only that reached statistical
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significance for an association (aOR 2.1, 95% CI 1.2–3.8; Table 4). The combined effect of
cold symptoms and acetaminophen was not higher than that we would expect from each of
their independent effects; the association between acetaminophen and microtia persisted
when we adjusted for possible confounding by cold symptoms.
Microtia characterized by Marx as type I was most common (39.7%), followed by types 2, 3
and 4 (35.1, 17.8, and 3.4%, respectively). Cases from hospitals at low altitude (< 2,500 m)
tended to have more severe types of microtia than those from hospitals at high altitude
(Table 5).
One hundred cases (8.4%) had at least one relative affected with microtia, compared to only
6 controls (0.5%) who had any relatives with microtia (aOR 18.1, 95%CI 7.9–41.4; data not
shown). When we restricted our analyses to those cases with no family history of microtia,
no substantial differences in the associations studied were observed.
DISCUSSION
Although several published reports have attempted to identify risk factors for microtia, only
four of these have been case-control studies (Table 6) (Castilla and Orioli, 1986;
Mastroiacovo et al., 1995; Paput et al., 2011a; Paput et al., 2011b; Van Bennekom et al.,
2013). While they also recruited controls through population and hospital birth cohorts,
these ranged in size from 172 to 411 cases, and control participation rates were reported for
only one study (Van Bennekom et al., 2013) retaining the possibility that bias may have
accounted for some of the associations which were reported. Use of ECLAMC data
presented a unique opportunity to evaluate the association between microtia and various risk
factors since it contains data on 1,194 cases of isolated microtia. Since approximately 95%
of the controls agreed to participate, the prevalence of selection bias that may result was
minimized. This evaluation within this well established south-American study population
allowed us to evaluate exposures that may be specific for this high-risk population because
the geography, ancestry, and culture differ from those of populations previously described in
literature.
Our cases presented similar phenotypic characteristics to the ones described in previous
studies of microtia, such as higher proportion of males (56.6%) than expected in the general
population at birth (51.5%); for unilateral cases the right side was more commonly affected
than the left side, and in relation to severity of microtia, anotia (type 4) accounted for only a
small proportion of cases. However, while an association has been found between low birth
weight and microtia in three previous studies, including one using ECLAMC data from
1967–1977 (Castilla and Orioli, 1986; Forrester and Merz, 2005; Mastroiacovo et al., 1995),
we did not find a difference between the reported birth weights of cases and controls in our
study, this could be due to our adjustment in the analysis for hospital. Adjustment for birth
hospital may serve as a proxy for regional birth weight differences related to ethnicity,
nutrition, etc.
Our findings of a modest association between multiple births and microtia are consistent
with those reported previously (Forrester and Merz, 2005; Shaw et al., 2004); similarly, an
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association has been established between microtia and low maternal education (Canfield et
al., 2009a; Harris et al., 1996; Shaw et al., 2004) and we also found a modestly elevated risk
among women in the lowest education stratum.
We observed a higher risk of microtia among multiparous women, this increasing risk was
seen among women giving birth to their second (and subsequent) child, and doubled after
the 8th pregnancy. Multiparity as a risk factor for microtia has been reported in previous
studies; however a modestly increased risk (10%) was seen only in the stratum of highest
parity, defined in these studies as four or more pregnancies (Harris et al., 1996; Shaw et al.,
2004). The hypothesis given by these authors is a correlation between multiparity and short
interpregnancy intervals (<6 months) which may be associated with an increased risk of
birth defects, possibly because of nutrient depletion (Grisaru-Granovsky et al., 2009). In
order to rule out this possibility, we repeated analyses while looking simultaneously at parity
and interpregnancy interval, and did not find that either variable had a modifying effect on
the association between the other and microtia risk. Contrary to our findings, Mastroiacovo
et al. (1995) reported 55.3% of cases’ mothers were primiparous compared to 50.5% of
controls’ mothers (p=0.34) whereas Duong et al (2012) found that primiparous women were
at a slightly higher risk for microtia (aORs: 1.06, 95%CI: 0.82–1.37) than multiparous
women. Studies of other birth defects have inconsistently observed a modest to null
association between multiparity and oral clefts and neural tube defects (Canfield et al.,
2009b; Duong et al., 2012; Hashmi et al., 2005; Vieira, 2004; Vieira and Orioli, 2002).
We did not find any association with older maternal or paternal age as seen in previous
studies. In population-based descriptive studies in Texas (Canfield et al., 2009a) and in
Hawaii (Forrester and Merz, 2005), a higher birth prevalence with increasing maternal age
was observed; likewise, Harris et al (1996) found an OR 1.92 (95% CI:0.96–3.85) for
mothers aged 35 years or older, however these findings might be the result of unidentified
chromosomal anomalies as they included cases associated with other birth defects in the
analysis. In the previous study in South America, paternal age was significantly higher in
cases (30.2 ±7.8) than in controls (27.6± 5.8).
Although Native American ancestry did show a slighter higher risk, we did not find an
association to race/ethnicity; this was not unexpected since cases and controls were matched
for hospital therefore there was a potential for overmatching of race/ethnicity. In studies
performed in the US population, Hispanics have been described as having higher risk for
microtia (Canfield et al., 2009a; Luquetti et al., 2011; Ramadhani et al., 2009; Shaw et al.,
2004); however it is not clear what aspect of the ancestry admixture among the U.S.
Hispanic population this is related to.
We were unable to evaluate altitude in relation to the occurrence of microtia in these case-
control analysis because of the overmatching between cases and controls in relation to these
potential risk factors. However, we compared severity of microtia between cases from
hospitals at low and high altitudes and observed a tendency to more severe microtia in cases
from low altitude hospitals. Previous studies, one of them using ECLAMC data, have shown
a higher prevalence of microtia in population living at high altitude (Castilla et al., 1999;
González-Andrade et al., 2010). It is important to highlight that in South America, altitude
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and ancestry are strongly correlated; populations at high altitude have a much higher
proportion of Native American and a much lower of African ancestry when compared to the
populations living at a low altitude. Thus, it is still unclear if altitude is a risk factor, due to
chronic exposure to hypoxia or different diet habits, or if there is a genetic susceptibility
related to ancestry or if there is a combined effect of both altitude and ancestry.
The maternal illness during the prenatal period most substantially associated with microtia
was a history of cold-like symptoms. Fewer than five case mothers reported having maternal
diabetes in the first trimester, a condition found to be associated with microtia in several
studies (Correa et al., 2008; Mastroiacovo et al., 1995; Wang et al., 2002). Although Van
Bennekom et al. (2013) observed that maternal hypertension was more frequently reported
among mothers of cases of microtia than controls (OR, 1.6; 95% CI, 1.0–2.5), we did not
find an association with this condition.
We observed an increased risk of microtia among women who used any medication during
the first trimester of pregnancy. The analysis by specific group of drugs showed a higher
risk of microtia among mothers who used analgesics, antibiotics, antispasmodics and
varying combinations of progestogens and estrogens. Among analgesics, use of
acetaminophen was the most commonly reported and the only one that reached statistical
significance. However, multiple previous studies have evaluated the effect of acetaminophen
use during the first trimester and overall no association was found with any birth defects
using population based birth cohorts (Aselton et al., 1985; Jick et al., 1981; Rebordosa et al.,
2008; Thulstrup et al., 1999). The positive association observed in our study could be due to
exposure misclassification (timing of use) or recall bias, particularly for a common
medication such as acetaminophen. Feldkamp et al (2010) reported a decreased risk when
acetaminophen was used during a febrile condition in the mother for some birth defects,
including microtia. Our analysis stratifying by maternal fever or cold-like symptoms
suggested that the association present in these data is not the result of confounding (and
spurious presence) by colds or cold like symptoms during the pregnancy since the
association persisted after adjustment and was similar within groups defined by presence or
absence of cold like symptoms during pregnancy.
Contrary to our findings, a previous study by the National Birth Defects Prevention Study
(NBDPS) on antibiotics and risk of selected birth defects found no association with microtia
(aOR 0.9, 95%CI 0.6–1.4) (Crider et al., 2009). A notable difference between our study and
the NBDPS includes timing of maternal interview (at birth vs. 6 months to 2 years) which
could have lead to recall bias in the NBDPS data, i.e., with more time between birth and the
study interview, the mothers of the cases could potentially reevaluate their exposures more
intensively than controls. However, it was not possible to determine what aspect of
antibiotic use was associated with the higher risk; the actual use of the antibiotic
medications or the infections that lead to their use. In a study by Van Bennekon (Van
Bennekom et al., 2013) no association with vasoactive drugs (NSAIDs, decongestants,
bronchodilators, antihypertensive) use in the first trimester and microtia was found. We did
observe an association with use of antihypertensives; however this was based on a small
number of exposed mothers and therefore could be a spurious finding.
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We were unable to assess the association between maternal use of medications which have
been strongly associated with microtia such as retinoids, mycophenolate mofetil,
thalidomide, and carbimazole/methimazole (Anderka et al., 2009; Carey et al., 2006; Gripp
et al., 2011), since no use was reported by mothers of cases or controls in our study; it is
encouraging that these medications appear not to be used by pregnant women in the
population being studied.
We observed an association both with use of tobacco and alcohol during pregnancy.
Smoking and alcohol use was not previously reported to be associated with microtia in the
two case-control studies that looked specifically at these risk factors for isolated microtia,
however both studies had relatively small sample sizes of 114 (Mastroiacovo et al., 1995)
and 296 cases (Van Bennekom et al., 2013) compared to ours. In Utah,
(Srisukhumbowornchai et al., 2012) a study on smoking and birth defects showed a weak
association between maternal smoking at any time during pregnancy and microtia (aOR
1.08, 95%CI 0.35–3.41). In a study evaluating the relation between paternal smoking and
birth defects, there appeared to be an elevated risk of offspring with microtia among men
who smoked (Zhang et al., 1992). Nicotine is believed to cause oxidative stress that could be
related to neural crest disturbance, in a similar manner as hyperglycemia. Likewise, alcohol
has been involved in neural crest cell migration impairment.
Our findings should be interpreted in light of the study limitations and strengths. Data
quality must always be acknowledged as a possible limitation. However, the diagnosis of the
birth defect, in this case, microtia, is made by trained ECLAMC physicians and described
following a standardized protocol. Case ascertainment occurs by active examination of all
births in participating hospitals which reduces potential case selection bias due to
incomplete ascertainment. Assessment of exposure is based on a questionnaire administered
to the mothers by trained interviewers. Following ECLAMC protocol, the maternal
interview occurs in the first three days after birth reducing recall bias. Coding was
performed centrally until 2005 and since then through an automated system that is reviewed
periodically for inconsistencies.
In a recent analysis using ECLAMC data, Poletta et al (2012) found 29 birth defects were
significantly associated with acetaminophen use when using healthy live-births as controls
as in the current study. They compared their data to the study on acetaminophen by
Feldkamp et al (2010) that showed no association to any of the 50 major birth defects
studied, however it must be acknowledged that the proportion of exposed population in that
study was much higher than in ECLAMC (~ 45% compared to ~ 3%). Using additional set
of sick controls and case-only approach, they suggested that this was presumably caused by
bias resulting from differential misclassification that decreased with the increased proportion
of exposed controls. This same bias could also explain the difference observed in the present
study for acetaminophen and other exposures, particularly those with low proportion of
exposed controls.
Smoking, alcohol and recreational drugs may have been underreported because of social
stigma related to their use, particularly during pregnancy; furthermore the degree of
underreporting may vary for cases and controls. We also acknowledge that even with the
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relatively large sample size, there were small numbers of exposed cases for several of the
exposures investigated, thus some of these estimates are unstable. Questions for use of
medications and maternal illnesses are open-ended, which may lead to potential loss of
information and recall bias from case-mothers. Control for confounding was based on
multivariable regression analyses using a set of covariates determined a priori base on a
literature review; there was little difference between crude and adjusted ORs, suggesting that
the covariates had small effect on estimates. However it is still possible that residual
confounding or effect modification may have influenced some of our findings, particularly
those related to race/ethnicity and altitude.
This large sample size and relatively large exposure rates enabled us to detect the presence
of even relatively weak associations. We have identified potential risk factors (multiparity,
maternal use of tobacco, some medications and cold-like symptoms during the 1st trimester)
of which the few previous studies had conflicting results adding to the evidence that they are
very likely implicated in the cause of microtia. Some, such as use of tobacco and the use of
medications are modifiable risk factors, and campaigns for prevention of birth defects might
be reinforced using these data. Further studies on the interrelation between genetic and non-
genetic risk factors and their causal pathways will enable us to understand better the etiology
of microtia.
Acknowledgments
Grant information and grant numbers: This work was supported by the National Institute on Deafness and Other
Communication Disorders at the National Institutes of Health (grant number K99DC011282).
References
Aase JM, Tegtmeier RE. Microtia in New Mexico: evidence for multifactorial causation. Birth defects
original article series. 1977; 13(3A):113–116. [PubMed: 884237]
Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. Reviewing the evidence for
mycophenolate mofetil as a new teratogen: case report and review of the literature. American
journal of medical genetics. 2009; 149A(6):1241–1248. [PubMed: 19441125]
Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A. First-trimester drug use and congenital
disorders. Obstetrics and gynecology. 1985; 65(4):451–455. [PubMed: 3982720]
Canfield MA, Langlois PH, Nguyen LM, Scheuerle AE. Epidemiologic features and clinical subgroups
of anotia/microtia in Texas. Birth defects research. 2009a; 85:905–913. [PubMed: 19760683]
Canfield MA, Marengo L, Ramadhani TA, Suarez L, Brender JD, Scheuerle A. The prevalence and
predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidemiol. 2009b; 23(1):41–
50. [PubMed: 19228313]
Carey, JC.; Park, AH.; Muntz, HR. External Ear. In: Stevenson, RE., editor. Human malformations
and related anomalies. Oxford; New York: Oxford University Press; 2006. p. 329-338.
Castilla EE, Lopez-Camelo JS, Campana H. Altitude as a risk factor for congenital anomalies.
American journal of medical genetics. 1999; 86(1):9–14. [PubMed: 10440822]
Castilla EE, Orioli IM. Prevalence rates of microtia in South America. International journal of
epidemiology. 1986; 15(3):364–368. [PubMed: 3771073]
Castilla EE, Orioli IM. ECLAMC: the Latin-American collaborative study of congenital
malformations. Community genetics. 2004; 7(2–3):76–94. [PubMed: 15539822]
Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso
TJ, Waller DK, Reece EA. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;
199(3):237, e231–239. [PubMed: 18674752]
Luquetti et al. Page 9
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during
pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr
Adolesc Med. 2009; 163(11):978–985. [PubMed: 19884587]
Duong HT, Hoyt AT, Carmichael SL, Gilboa SM, Canfield MA, Case A, McNeese ML, Waller DK. Is
maternal parity an independent risk factor for birth defects? Birth defects research. 2012; 94(4):
230–236. [PubMed: 22371332]
Feldkamp ML, Meyer RE, Krikov S, Botto LD. Acetaminophen use in pregnancy and risk of birth
defects: findings from the National Birth Defects Prevention Study. Obstetrics and gynecology.
2010; 115(1):109–115. [PubMed: 20027042]
Forrester MB, Merz RD. Descriptive epidemiology of anotia and microtia, Hawaii, 1986–2002.
Congenital anomalies. 2005; 45(4):119–124. [PubMed: 16359491]
González-Andrade F, López-Pulles R, Espín VH, Paz-y-Miño C. High altitude and microtia in
Ecuadorian patients. Journal of Neonatal-Perinatal Medicine. 2010; 3(2):109–116.
Gripp KW, Kuryan R, Schnur RE, Kothawala M, Davey LR, Antunes MJ, Reichard KW, Schneider A,
Hall BD. Grade 1 microtia, wide anterior fontanel and novel type tracheo-esophageal fistula in
methimazole embryopathy. American journal of medical genetics. 2011; 155A(3):526–533.
[PubMed: 21344626]
Grisaru-Granovsky S, Gordon ES, Haklai Z, Samueloff A, Schimmel MM. Effect of interpregnancy
interval on adverse perinatal outcomes--a national study. Contraception. 2009; 80(6):512–518.
[PubMed: 19913144]
Harris J, Kallen B, Robert E. The epidemiology of anotia and microtia. Journal of medical genetics.
1996; 33(10):809–813. [PubMed: 8933331]
Hashmi SS, Waller DK, Langlois P, Canfield M, Hecht JT. Prevalence of nonsyndromic oral clefts in
Texas: 1995–1999. American journal of medical genetics. 2005; 134(4):368–372. [PubMed:
15779018]
Husain T, Langlois PH, Sever LE, Gambello MJ. Descriptive epidemiologic features shared by birth
defects thought to be related to vascular disruption in Texas, 1996–2002. Birth defects research.
2008; 82(6):435–440. [PubMed: 18383510]
Jaffe BF. Incidence of ear diseases in Navajo Indians. The Laryngoscope. 1969; 79(12):2126.
[PubMed: 5362681]
Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First-trimester drug use and congenital
disorders. JAMA. 1981; 246(4):343–346. [PubMed: 7241780]
Luquetti DV, Leoncini E, Mastroiacovo P. Microtia-anotia: a global review of prevalence rates. Birth
defects research. 2011; 91(9):813–822. [PubMed: 21656661]
Mastroiacovo P, Corchia C, Botto LD, Lanni R, Zampino G, Fusco D. Epidemiology and genetics of
microtia-anotia: a registry based study on over one million births. Journal of medical genetics.
1995; 32(6):453–457. [PubMed: 7666397]
Nelson SM, Berry RI. Ear disease and hearing loss among Navajo children--a mass survey. The
Laryngoscope. 1984; 94(3):316–323. [PubMed: 6700346]
Paput L, Banhidy F, Czeizel AE. Association of drug treatments in pregnant women with the risk of
external ear congenital abnormalities in their offspring: a population-based case-control study.
Congenital anomalies. 2011a; 51(3):126–137. [PubMed: 21848996]
Paput L, Czeizel AE, Banhidy F. Maternal diseases and risk of isolated ear abnormalities in their
children. Cent Eur J Public Health. 2011b; 19(3):170–176. [PubMed: 22026295]
Poletta FA, Lopez Camelo JS, Gili JA, Leoncini E, Castilla EE, Mastroiacovo P. Methodological
approaches to evaluate teratogenic risk using birth defect registries: advantages and disadvantages.
PloS one. 2012; 7(10):e46626. [PubMed: 23056376]
Ramadhani T, Short V, Canfield MA, Waller DK, Correa A, Royle M, Scheuerle A. Are birth defects
among Hispanics related to maternal nativity or number of years lived in the United States? Birth
defects research. 2009; 85(9):755–763. [PubMed: 19350653]
Rebordosa C, Kogevinas M, Horvath-Puho E, Norgard B, Morales M, Czeizel AE, Vilstrup H,
Sorensen HT, Olsen J. Acetaminophen use during pregnancy: effects on risk for congenital
abnormalities. Am J Obstet Gynecol. 2008; 198(2):178 e171–177. [PubMed: 18226618]
Luquetti et al. Page 10
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Shaw GM, Carmichael SL, Kaidarova Z, Harris JA. Epidemiologic characteristics of anotia and
microtia in California, 1989–1997. Birth defects research. 2004; 70(7):472–475. [PubMed:
15259037]
Srisukhumbowornchai S, Krikov S, Feldkamp ML. Self-reported maternal smoking during pregnancy
by source in Utah, 2003–2007. Birth defects research. 2012; 94(12):996–1003. [PubMed:
22821801]
Stevenson, RE. Human malformations and related anomalies. Oxford; New York: Oxford University
Press; 2006.
Suutarla S, Rautio J, Ritvanen A, Ala-Mello S, Jero J, Klockars T. Microtia in Finland: comparison of
characteristics in different populations. International journal of pediatric otorhinolaryngology.
2007; 71(8):1211–1217. [PubMed: 17548114]
Thulstrup AM, Sorensen HT, Nielsen GL, Andersen L, Barrett D, Vilstrup H, Olsen J. Fetal growth
and adverse birth outcomes in women receiving prescriptions for acetaminophen during
pregnancy. EuroMap Study Group. Am J Perinatol. 1999; 16(7):321–326. [PubMed: 10614698]
Van Bennekom CM, Mitchell AA, Moore CA, Werler MM. Vasoactive exposures during pregnancy
and risk of microtia. Birth defects research. 2013; 97(1):53–59. [PubMed: 23180593]
Vieira AR. Birth order and neural tube defects: a reappraisal. J Neurol Sci. 2004; 217(1):65–72.
[PubMed: 14675612]
Vieira AR, Orioli IM. Birth order and oral clefts: a meta analysis. Teratology. 2002; 66(5):209–216.
[PubMed: 12397628]
Wang R, Martinez-Frias ML, Graham JM Jr. Infants of diabetic mothers are at increased risk for the
oculo-auriculo-vertebral sequence: A case-based and case-control approach. The Journal of
pediatrics. 2002; 141(5):611–617. [PubMed: 12410187]
Yang J, Carmichael SL, Kaidarova Z, Shaw GM. Risks of selected congenital malformations among
offspring of mixed race-ethnicity. Birth defects research. 2004; 70(10):820–824. [PubMed:
15390318]
Zhang J, Savitz DA, Schwingl PJ, Cai WW. A case-control study of paternal smoking and birth
defects. International journal of epidemiology. 1992; 21(2):273–278. [PubMed: 1428480]
Zhang QG, Zhang J, Yu P, Shen H. Environmental and Genetic Factors Associated with Congenital
Microtia: A Case-Control Study in Jiangsu, China, 2004 to 2007. Plastic and reconstructive
surgery. 2009; 124(4):1157–1164. [PubMed: 19935299]
Luquetti et al. Page 11
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Luquetti et al. Page 12
Table 1
Demographic Characteristics of Controls and Cases with Isolated Microtia in ECLAMC, Period: 1982–2011.
Controls n=1,194
Mean (SD)
Isolated microtia n=1,194
Mean (SD)
Birth weight 3181.7 (560.1) 3163.0 (613.1)
Gestational Age (weeks) 38.9 (2.2) 39.0 (2.4)
Parity 2.4 (1.8) 2.7 (2.0)
Maternal age 25.7 (6.6) 26.1 (6.4)
Paternal age 29.1 (7.8) 29.5 (7.5)
SD: standard deviation
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Table 2
Adjusted Odds Ratio for the Association between Isolated Microtia and Selected Risk Factors, in ECLAMC,
Period: 1982–2011.
Controls (n=1,194) Isolated microtia (n=1,194)
aOR (95% CI) ANo. (%) No. (%)
Multiple births (≥2) 18 (1.5) 23 (1.9) 1.2 (0.6–2.3)
Parity
 Primipara 455 (40.4) 364 (32.0) 1.00 (ref)
 2–7 pregnancies 653 (57.9) 734 (64.6) 1.5 (1.2–1.8)
 ≥ 8 pregnancies 19 (1.7) 39 (3.4) 2.8 (1.6–5.2)
Number of cigarettes (daily) B
 0 251 (83.4) 234 (76.2) 1.00 (ref)
 ≥1 50 (16.6) 73 (23.8) 1.7 (1.1–2.6)
Reported using alcohol during pregnancy B 55 (18.6) 73 (24.2) 1.4 (0.9–2.1)
Reported binge drinking B
 Never drank 238 (82.1) 213 (78.0) 1.00 (ref)
 Drank, but never binged 39 (13.4) 42 (15.4) 1.2 (0.7–1.9)
 Engaged in binge drinking (≥1) 13 (4.5) 18 (6.6) 1.4 (0.7–3.1)
Reported using illegal drugs during pregnancy B 7 (2.6) 7 (2.6) 1.0 (0.3–2.9)
Reported using medications during 1st trimester of pregnancy 364 (31.0) 532 (40.2) 1.5 (1.3–1.8)
Acute diseases during pregnancy 371 (31.7) 455 (38.6) 1.4 (1.2–1.6)
Chronic diseases 101 (8.6) 131 (11.2) 1.3 (1.0–1.7)
Maternal years of school
 > 8 years 723 (60.6) 694 (58.1) 1.00 (ref)
 < 8 years 471 (39.4) 500 (41.9) 1.1 (0.9–1.3)
Paternal years of school
 > 8 years 760 (63.7) 715 (59.9) 1.00 (ref)
 < 8 years 434 (36.3) 479 (40.1) 1.2 (1.0–1.4)
Maternal occupation B
 Housewife 813 (69.8) 747 (64.2) 1.00 (ref)
 Employed outside the home 352 (30.2) 417 (35.8) 1.3 (1.1–1.5)
Paternal occupation
 Blue collar 555 (53.2) 568 (53.0) 1.00 (ref)
 White collar 489 (46.8) 503 (47.0) 1.0 (0.8–1.2)
Parental consanguinity 12 (1.0) 16 (1.4) 1.3 (0.6–2.7)
Race/Ethnicity
 Native American (any) 925 (77.5) 946 (79.2) 1.1 (0.9–1.3)
 White (any) 127 (10.6) 112 (9.4) 0.9 (0.7–1.1)
 Black (any) 83 (7.0) 81 (6.8) 1.0 (0.7–1.3)
aOR: Adjusted Odds Ratio
AAdjusted by sex, maternal age, hospital and year of birth.
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B
Data was collected from 2002 onwards. We also separately fewer than- and more than- 10 cigarettes/day as separate categories and found similar
risks for each.
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Table 3
Selected Maternal Acute and Chronic Diseases during the 1st Trimester of Pregnancy in ECLAMC, Period:
1982–2011.
Controls (n=962) Isolated microtia (n=932)
No. (%) No. (%) aOR (95% CI) A
Nausea/Vomiting 20 (2.3) 27 (3.3) 1.4 (0.8–2.6)
Asthma 4 (0.5) 10 (1.2) 2.7 (0.8–8.6)
Cold-like symptoms 17 (1.9) 35 (4.2) 2.2 (1.2–3.9)
Hypertension 7 (0.8) 6 (0.7) 0.9 (0.3–2.8)
Respiratory infection 3 (0.3) 7 (0.9) 2.5 (0.6–9.7)
Urinary infection 43 (4.8) 41 (4.9) 1.0 (0.7–1.6)
aOR: Adjusted Odds Ratio
AAdjusted by sex, maternal age, hospital and year of birth.
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Table 4
Selected Medications Used by Mothers during 1st Trimester of Pregnancy in ECLAMC, Period: 1982–2011.
Controls (n=764) Isolated microtia (n=777)
No. (%) No. (%) aOR (95% CI) A
Analgesics B 31 (5.1) 59 (10.4) 2.2 (1.4–3.4)
Non-steroidal antiinflammatories 6 (1.0) 12 (2.3) 2.1 (0.8–5.7)
Antacids 10 (1.7) 8 (1.6) 0.9 (0.4–2.3)
Antibiotics C 39 (6.3) 58 (10.3) 1.6 (1.1–2.5)
Antiemetics 2 (0.3) 8 (1.6) 4.5 (1.0–21.4)
Antihypertensives D 3 (0.5) 9 (1.7) 3.6 (1.0–13.7)
Antispasmodics 8 (1.4) 19 (3.6) 2.8 (1.2–6.5)
Anxiolytics 1 (0.2) 6 (1.2) 7.4 (0.9–62.2)
Drugs for Functional bowels diseases 7 (1.2) 21 (4.0) 3.6 (1.5–8.5)
Progestogens/estrogens combinations 4 (0.7) 20 (3.8) 6.1 (2.1–18.1)
Vitamins and minerals 122 (17.4) 126 (19.9) 1.2 (0.9–1.6)
aOR: Adjusted Odds Ratio
AAdjusted by sex, maternal age, hospital and year of birth.
BAcetylsalicylic acid, acetaminophen, metamizole, the more frequently reported analgesics presented similar ORs
CAmoxicillin, ampicillin, cephalexin, the more frequently reported antibacterials presented similar ORs
D
Metildopa the more frequently reported antihypertensive presented similar OR
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Table 5
Type of microtia in low and high altitude in ECLAMC, Period: 1997–2011 A
Low Altitude (< 2,500 m B) High Altitude (> 2,500 m B) Total cases
n=538 n=283 n=821
Type of microtia (Marx classification) % % %
 Type 1 41.4 41.3 39.7
 Type 2 33.5 42.4 35.1
 Type 3 20.3 15.2 17.8
 Type 4 4.8 1.1 3.4
A
Type of microtia was only recorded from 1997 onwards
B8,200 feet
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Luquetti et al. Page 18
Ta
bl
e 
6
Su
m
m
ar
iz
ed
 fi
nd
in
gs
 o
f p
re
vi
ou
s c
as
e-
co
nt
ro
l s
tu
di
es
 e
va
lu
at
in
g 
ris
k 
fa
ct
or
s f
or
 is
ol
at
ed
 m
ic
ro
tia
Pr
es
en
t s
tu
dy
V
an
 B
en
ne
ko
m
 e
t a
l, 
20
13
Pa
pu
t e
t a
l, 
20
11
M
as
tr
oi
ac
ov
o 
et
 a
l, 
19
95
C
as
til
la
 &
 O
ri
ol
i, 
19
86
Po
pu
la
tio
n
So
ut
h 
A
m
er
ic
a
U
SA
H
un
ga
ry
Ita
ly
So
ut
h 
A
m
er
ic
a
Pe
rio
d
19
82
–2
01
1
19
97
–2
00
5
19
80
–1
99
6
19
83
–1
99
2
19
67
–1
97
7
Pr
eg
na
nc
y 
ou
tc
om
e
Li
ve
bi
rth
Li
ve
bi
rth
Li
ve
- a
nd
 st
ill
bi
rth
Li
ve
- a
nd
 st
ill
bi
rth
Li
ve
bi
rth
N
 c
as
es
a
1,
19
4
30
4
35
4
11
4
18
4
N
 c
on
tro
lsb
1,
19
4
6,
74
7
38
,1
51
64
8
18
4
M
at
ch
in
g
Se
x,
 ti
m
e 
an
d 
pl
ac
e 
of
 b
irt
h
Ti
m
e 
an
d 
pl
ac
e 
of
 b
irt
h
Se
x,
 ti
m
e 
an
d 
pl
ac
e 
of
 b
irt
h
Ti
m
e 
an
d 
pl
ac
e 
of
 b
irt
h
Se
x,
 ti
m
e 
an
d 
pl
ac
e 
of
 b
irt
h
D
es
cr
ip
tiv
e 
m
ea
su
re
s
M
at
er
na
l a
ge
=
=
=
=
=
Pa
te
rn
al
 a
ge
=
n
a
=
=
>
B
irt
hw
ei
gh
t
=
n
a
<
<
<
G
es
ta
tio
na
l a
ge
=
n
a
=
=
=
Se
x 
(m
ale
 %
)
56
.6
60
.0
54
.0
52
.6
n
a
M
ea
su
re
s o
f A
ss
oc
ia
tio
nc
 
O
R 
(95
% 
CI
)
M
ul
tip
le
 b
irt
hs
 (≥
2)
1.
2 
(0.
6–
2.3
)
1.
7 
(0.
8–
3.5
)
=
n
a
n
a
Pa
rit
y 
(≥
2)
1.
5 
(1.
2–
1.8
)
=
>
=
>
M
at
er
na
l u
se
 o
f a
lc
oh
ol
1.
4 
(0.
9–
2.1
)
=
=
=
n
a
M
at
er
na
l s
m
ok
in
g
1.
7 
(1.
1–
2.6
)
1.
0 
(0.
5–
1.7
)
=
=
n
a
M
at
er
na
l u
se
 o
f m
ed
ic
at
io
ns
 
1.
 N
SA
ID
s
2.
1 
(0.
8–
5.7
)
1.
3 
(1.
0–
1.8
)
n
a
n
a
n
a
 
2.
 A
nt
ih
yp
er
te
ns
iv
es
3.
6 
(1.
0–
13
.7)
0.
9 
(0.
3–
3.1
)
n
a
n
a
n
a
 
3.
 A
na
lg
es
ic
s
2.
2 
(1.
4–
3.4
)
n
a
=
n
a
n
a
 
4.
 A
nt
ib
io
tic
s
1.
6 
(1.
1–
2.5
)
n
a
=
n
a
=
M
at
er
na
l A
cu
te
 a
nd
 C
hr
on
ic
 d
ise
as
es
 (1
st
tr
im
es
te
r)
 
1.
 C
ol
d-
lik
e 
sy
m
pt
om
s
2.
2 
(1.
2–
3.9
)
n
a
4.
3 
(1.
9–
7.4
)
n
a
n
a
 
2.
 H
yp
er
te
ns
io
n
0.
9 
(0.
3–
2.8
)
1.
1 
(0.
6–
2.1
)
0.
8 
(0.
5–
1.3
)
=
n
a
 
3.
 D
ia
be
te
s m
el
lit
us
2.
2 
(0.
2–
24
.3)
3.
4 
(1.
3–
8.5
)
1.
5 
(0.
5–
4.7
)
8.
7 
(1.
2–
96
.4)
 d
n
a
 
4.
 R
es
pi
ra
to
ry
 in
fe
ct
io
n
2.
5 
(0.
6–
9.7
)
n
a
1.
3 
(0.
4–
2.4
)
n
a
n
a
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Luquetti et al. Page 19
Pr
es
en
t s
tu
dy
V
an
 B
en
ne
ko
m
 e
t a
l, 
20
13
Pa
pu
t e
t a
l, 
20
11
M
as
tr
oi
ac
ov
o 
et
 a
l, 
19
95
C
as
til
la
 &
 O
ri
ol
i, 
19
86
 
5.
 U
rin
ar
y 
in
fe
ct
io
n
1.
0 
(0.
7–
1.6
)
n
a
1.
1 
(0.
2–
2.4
)
n
a
n
a
R
ac
e/
et
hn
ic
ity
=
H
isp
an
ic
se
n
a
n
a
=
M
at
er
na
l y
ea
rs
 o
f s
ch
oo
l (
≤1
2)
1.
1 
(0.
9–
1.3
)
<
n
a
=
=
M
at
er
na
l o
cc
up
at
io
n 
(le
ss 
sk
ille
d)
1.
3 
(1.
0–
1.6
)
n
af
<
 s
ki
lle
d 
w
or
ke
rs
=
=
a
If 
od
ds
 ra
tio
 (O
R)
 w
ere
 pr
ov
ide
d i
n t
he
 m
an
us
cri
pts
 w
e r
ep
ort
ed
 th
em
 w
ith
 th
e r
esp
ec
tiv
e c
on
fid
en
ce
 in
ter
va
ls 
(C
I).
O
th
er
w
ise
 w
e 
us
ed
: (
=)
 no
 di
ffe
ren
ce
 be
tw
ee
n c
ase
s a
nd
 co
ntr
ols
 w
as 
fou
nd
; (
>)
 ca
ses
 ha
d h
igh
er 
va
lue
s t
ha
n c
on
tro
ls;
 (<
) c
ase
s h
ad
 lo
we
r v
alu
es 
tha
n c
on
tro
ls
b A
ll 
stu
di
es
 a
lso
 a
na
ly
ze
d 
m
ic
ro
tia
 a
ss
oc
ia
te
d 
w
ith
 o
th
er
 d
ef
ec
ts,
 b
ut
 w
e 
di
d 
no
t i
nc
lu
de
 th
os
e 
re
su
lts
 si
nc
e 
fo
r t
hi
s s
tu
dy
 w
e 
an
al
yz
ed
 o
nl
y 
iso
la
te
d 
ca
se
s.
c A
ll 
stu
di
es
 u
se
d 
no
n-
m
al
fo
rm
ed
 in
fa
nt
s a
s c
on
tro
ls.
 P
ap
ut
 e
t a
l u
se
d 
an
 a
dd
iti
on
al
 se
t o
f m
al
fo
rm
ed
 in
fa
nt
s, 
bu
t w
e 
on
ly
 a
dd
ed
 in
 th
is 
ta
bl
e 
th
e 
re
su
lts
 fr
om
 th
e 
co
m
pa
ris
on
s w
ith
 th
e 
no
n-
m
al
fo
rm
ed
in
fa
nt
s.
d A
na
ly
sis
 d
on
e 
on
 c
as
es
 w
ith
 is
ol
at
ed
 m
ic
ro
tia
 a
nd
 a
ss
oc
ia
te
d 
w
ith
 o
th
er
 c
on
ge
ni
ta
l a
no
m
al
ie
s.
e M
ot
he
rs
 o
f i
nf
an
ts 
w
ith
 is
ol
at
ed
 m
ic
ro
tia
 w
er
e 
m
or
e 
lik
el
y 
to
 b
e 
of
 H
isp
an
ic
 o
rig
in
f M
ot
he
rs
 o
f i
nf
an
ts 
w
ith
 is
ol
at
ed
 m
ic
ro
tia
 w
er
e 
m
or
e 
lik
el
y 
to
 h
av
e 
lo
w
er
 h
ou
se
ho
ld
 in
co
m
es
“
n
a”
: 
da
ta
 n
ot
 a
va
ila
bl
e/
N
SA
ID
s: 
N
on
-s
te
ro
id
al
 a
nt
iin
fla
m
m
at
or
ie
s
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2014 November 01.
